| ALK | Anaplastic lymphoma kinase |
| AMP | Association for Molecular Pathology |
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 |
| CAP | College of American Pathologists |
| cfDNA | Cell-free DNA |
| ctDNA | Circulating-tumour DNA |
| CI | Confidence interval |
| CNV | Copy number variation |
| ddPCR | Droplet digital polymerase chain reaction |
| ECOG | Eastern Cooperative Oncology Group |
| EGFR | Epidermal growth factor receptor |
| HER2 | Human epidermal growth factor receptor 2 |
| HR | Hazard ratio |
| IASLC | International Association for the Study of Lung Cancer |
| KRAS | Kirsten rat sarcoma |
| LB | Liquid biopsy |
| MeSH | Medical subject headings |
| MET | Mesenchymal–epithelial transition factor |
| mOS | Medial overall survival |
| mPFS | Median progression-free survival |
| MRD | Minimal residual disease |
| NGS | Next-generation sequencing |
| NSCLC | Non-small-cell lung cancer |
| NOS | Newcastle–Ottawa Scale |
| NTRK | Neurotrophic tyrosine receptor kinase |
| ORR | Overall response rate |
| OS | Overall survival |
| PCR | Polymerase chain reaction |
| PD-L1 | Programmed-death-ligand 1 |
| PFS | Progression-free survival |
| pHR | Pooled hazard ratio |
| PRISMA | Preferred Reporting Items for Systemic Review and Meta-Analyses |
| RET | Rearranged during transfection |
| ROS-1 | C-ros oncogene 1 |
| TKI | Tyrosine kinase inhibitor |
| TSG | Tumour suppressor gene |
| VAF | Variant allele frequency |